Page results
-
This patient information has been written for patients who are being given post exposure prophylaxis.
-
Volunteers are a highly valued part of the team at UCLH. Volunteering is a great way of giving back, doing something different and get some experience. Roles tend to be for a minimum of half a day a week for 6 months. For most of our roles you don’t necessarily need have to have prior experience as the key things we are looking for are great people skills and an ability to give us a regular commitment.
-
This information is for patients who have fibroids. It contains information about what fibroids are, how they can affect you and what treatments are available.
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
Being diagnosed with cancer can be a difficult time for you and those close to you. This page gives you an overview of the care you can expect to receive as our patient at University College London Hospitals NHS Foundation Trust (UCLH). It also introduces different types of healthcare professionals you may meet along the way.
-
This booklet explains what stem cells are and how they are collected from your blood. It includes information about what happens before, during and after the collection, and how the cells are stored.
-
The flow cytometry laboratory provides a Haematological Malignancy diagnostic service which includes chronic and acute leukaemias and lymphomas.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Alternatives to Accident and Emergency (A&E) and attending the Emergency Department (Casualty) at UCLH
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer